Figure 1From: Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluationCourse of L.major infection in BALB/c mice vaccinated with ĪHSP70-II promastigotes. BALB/c mice (n = 5) were inoculated with 1 Ć 107 ĪHSP70-II promastigotes and, 4 weeks later, challenged with 1,000 metacyclic promastigotes of L. major. The control group (unvaccinated) was challenged with an identical inoculum of L. major. (A) Course of lesion progression. (B) Parasite burdens in spleen and popliteal lymph node (right foot). The data presented are representative of two experiments with similar results.Back to article page